Pseudomonas Aeruginosa

Infectious Disease·MeSH: Pseudomonas Infections

18 drugs in development·15 companies·1 clinical trial

Drug Pipeline by Phase

Approved(11)

Drug	Company
cayston	GILEAD SCIENCES, INC. (GILD)
cefepime	Seagen Inc. (SGEN)
cefepime	Atara Biotherapeutics, Inc. (ATRA)
ciprofloxacin	Prestige Consumer Healthcare Inc. (PBH)
ciprofloxacin	DR REDDYS LABORATORIES LTD (RDY)
ciprofloxacin	ANI PHARMACEUTICALS INC (ANIP)
ciprofloxacin	Altamira Therapeutics Ltd. (CYTOF)
ciprofloxacin	AMARIN CORP PLCUK (AMRN)
ciprofloxacin	SUNSET ISLAND GROUP (SUN)
tobi podhaler	Viatris Inc (VTRS)
zerbaxa	Curative Biotechnology Inc (CUBT)

Phase 3(1)

Drug	Company
AZD0292	ASTRAZENECA PLC (AZN)

Phase 2(5)

Drug	Company
AP-PA02	Armata Pharmaceuticals, Inc. (ARMP)
AR-101	Aridis Pharmaceuticals, Inc. (ARDS)
AR-501	Aridis Pharmaceuticals, Inc. (ARDS)
bx004	BiomX Inc. (PHGE)
bx004-a	BiomX Inc. (PHGE)

Phase 1/Phase 2(1)

Drug	Company
AP-PA03	Armata Pharmaceuticals, Inc. (ARMP)

BioSniper tracks 18 drugs in development for Pseudomonas Aeruginosa across 15 companies.

There are 1 clinical trial targeting Pseudomonas Aeruginosa tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.